Kenechukwu C. Ben-Umeh
Email address: Kenechukwu.Ben-Umeh@utah.edu
Kenechukwu obtained his Bachelor of Pharmacy degree from the University of Nigeria, Nsukka (UNN). He then worked as a Research Intern Pharmacist at the National Institute for Pharmaceutical Research and Development (NIPRD) for a year and as a Research Assistant at the International Research Centre for Excellence, Institute of Human Virology Nigeria. He learned about Health Economics and Outcomes Research (HEOR) through his involvement with the UNN student chapter of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). The burden of chronic illnesses in many African countries, especially Nigeria, and the undeniable complex relationship between treatment costs, payment burden, and health outcomes motivated him to apply for a Ph.D. at the University of Utah. Kene is excited by the enabling and collaborative research environment the Department of Pharmacotherapy offers and plans to work with renowned researchers and experts with academic and industrial links, building research competence and metamorphosing into an astute HEOR professional.
Pharmacoeconomics, health technology assessment (HTA), Pharmacoepidemiology, Real-world evidence.
Madeline Brendle, MPH
Email address: Madeline.Brendle@utah.edu
Madeline Brendle is a Ph.D. student at the Department of Pharmacotherapy at the University of Utah. She holds a B.A. in Neuroscience and an M.P.H concentrating in Healthcare Management from Boston University. During her M.P.H. education, she gained interest in health system analysis and research to identify how services and delivery of care can improve and best serve the patient population and surrounding community. Upon completion of her MPH, she began working as a research fellow at the Pharmacotherapy Outcomes Research Center in July 2019. During her year as a fellow, she worked on a number of projects and collaborated with expert faculty at PORC, all of whom allowed her to utilize the skills and knowledge gained at BU SPH and develop her expertise in HEOR. To provide additional value to pharmacotherapy research and evaluation, she decided to pursue a PhD in the Department of Pharmacotherapy.
Madeline’s primary research interest is in mental health pharmacotherapy and service delivery. She is interested in exploring and developing novel mental health treatment modalities and increasing access to treatment for marginalized groups. Her area of expertise includes evidence synthesis, outcomes research using secondary databases, cost-effectiveness analysis, and comparative effectiveness research.
Email address: firstname.lastname@example.org
Originally from India, Anindit earned his bachelor’s in biotechnology from Kurukshetra University and his MS from the department of pharmacology and toxicology at the University of Kansas. There, he was exposed to the field of HEOR and thus applied to the PhD program at the University of Utah. His research interests lie in assessing the clinical and economic utility of pharmacogenomics in reducing drug therapy problems in Cystic Fibrosis. He has been awarded Skaggs fellowship (2020-2021), ARUP fellowship (2021-2022), and has interned with Merck and Amgen during his training at the department.
Assessment of clinical and economic utility of pharmacogenomics in reducing drug therapy problems in Cystic Fibrosis
Khanh N. C. Duong
Email address: email@example.com
Khanh is currently a Ph.D. student at the Department of Pharmacotherapy. She received her bachelor's degree in pharmacy from Ho Chi Minh University of Medicine and Pharmacy, Vietnam, and her master's in Health Technology Assessment from Mahidol University, Thailand. Previously, she was an instructor at Ho Chi Minh Vietnam National University.
Evidence Synthesis, Health Technology Assessment, Economic Evaluation
Email address: firstname.lastname@example.org
Priyanka graduated with a Master of Science in Regulatory Affairs from Northeastern University, Boston in 2018. Subsequently, she worked as a research scholar at the University of Memphis School of Public Health where she supported ongoing research activities like literature review, manuscript preparation in the areas of population health, epidemiology, and health services research. She also has a BS and MS in Pharmacy from Mumbai University, India. She has worked in the pharmaceutical industry for 5 years and has experience in pharmaceutical research and development (R&D) and intellectual property rights (patents).
Priyanka's current research interest include pharmacoeconomics, outcomes research and real-world data analysis. Priyanka is currently involved in projects that focuses on patient centered outcomes, systematic reviews and meta-analysis and pharmacoeconomics.
Aditi A Kharat
Email address: email@example.com
Aditi is a pharmacist by training and is a current PhD student at the department of Pharmacotherapy. Prior to her doctoral studies, Aditi completed her masters in Pharmacy Administration from St. John’s University, New York, where she researched on economic burden of diabetes and chronic kidney diseases, and performed patient preference/discrete choice experiment studies for celiac disease patients. Her desire and passion to strengthen her understanding about the field of HEOR and the opportunity provided by the University of Utah to work on industry sponsored projects, made her pursue the doctoral training. Her research work is focused on pancreatic cancer and she is currently involved in projects that focus on healthcare resource utilization and medical expenditures, quality of care evaluations, and alternative payment model assessment for cancer patients.
Pharmacoeconomics, pharmacoepidemiology, health policy and outcomes research, health equity, health technology assessments, and real world evidence synthesis.
Email address: firstname.lastname@example.org
Tee was born in Bangkok, Thailand. He graduated in the Doctor of Pharmacy (Clinical Pharmacy) from the Faculty of Pharmacy, Mahidol University. He was working as a civil service officer in the position of Pharmacist, Practitioner Level at Thai Food and Drug Administration, Ministry of Public Health for 4 years with various responsibilities regarding the post-marketing, pre-marketing, and national policy drug regulation. Currently, he is pursuing the doctoral degree in the Department of Pharmacotherapy, the University of Utah with the ideas in mind that he wishes to find and implement better drug regulation innovation to improve the performance of his organization and the well-being of people in his home country.
Real-World Evidence, Patient-Centered Outcomes Research, Health Economics Outcomes Research, Comparative Effectiveness Research
Email address: Ratthanon.email@example.com
Ratthanon Prasitwarachot is originally from Thailand. He graduated with BPharm from Chiang Mai University and MSc in Advanced Pharmaceutical Manufacturing from University of Strathclyde. He has worked as a hospital pharmacist for three years and as an instructor for seven years. Although his previous degrees concentrated on pharmaceutical science, he is interested in pharmacoeconomics. He develops his skill by researching economic burden and cost-effectiveness analysis. Then, he decided to pursue his Ph.D. in Pharmacotherapy Outcome Research. Currently, he is a first-year Ph.D. student at the Department of Pharmacotherapy, University of Utah.
Economic Evaluation, Extended Cost-effectiveness analysis, Health technology assessment
Email address: firstname.lastname@example.org
Currently, I am a 3rd-year Ph.D. student here at the department of pharmacotherapy. Before joining the program, I was trained as a physician, obtained my medical degree from the University of Dhaka, and worked as a public health researcher at the icddr,b, Dhaka, Bangladesh, after graduation.
My research interest includes value assessment of innovative treatments, assessing outcomes in lung cancer patients applying real-world data, investigate drug-drug interaction utilizing large datasets, and evidence synthesis.